Obesity care in Chinese adults: from evidence to clinical practice
Precision Clinical Medicine · 13.10.2025 · 8 (4)
DOI: 10.1093/pcmedi/pbaf036 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Precision Clinical Medicine, online erschienen am 28.11.2025. Verfasst von Jing An und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Laboratory of Diabetes and Metabolism Research, West China Hospital, Sichuan University, Chengdu 610041, …. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Major Project, National Natural Science Foundation of China, West China Hospital, Sichuan University.
Abstract (Originalsprache)
More than 500 million Chinese adults suffered from overweight or obesity in 2023. The pandemic of obesity consumes healthcare and economic resources by imposing enormous burden from its complications such as cardiovascular, kidney and metabolic diseases. In response, China launched a series of important policy changes including “Weight Management Year”, facilitating the engagement of public health, clinical practitioners, industry and stakeholders in different fields. The shift triggered rapid evolution of technologies in obesity care including both treatment and prevention, which added great opportunities for all stakeholders. Nevertheless, challenges exist, including misdiagnosis of obesity secondary to other diseases, population disparity, indirect evidence supported by trials conducted in other ethnic groups, health inequalities and the collaboration across stakeholders with diverse backgrounds. Traditional Chinese diets such as Jiangnan Diet and activities such as Tai Chi represent tradition-based lifestyle interventions that provide Chinese people with cultural benefits. The evolution of technologies, especially digital healthcare and novel medications, will play critical roles in future obesity care in China. Policy makers and clinical and public health practitioners must make every effort to address the urgent crisis posed by obesity pandemic in China.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Laboratory of Diabetes and Metabolism Research, West China Hospital, Sichuan University, Chengdu 610041, China.
- MAGIC China Centre, Cochrane China Centre, Chinese Evidence-Based Medicine Centre, West China Hospital, Sichuan University, Chengdu 610041, China.
- Health Promotion and Food Nutrition & Safety Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu 610041, China.
- Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
- School of Public Health, Southern Medical University, Guangzhou 510515, China.
- Department of Endocrinology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
ORCID-Profile: Huijie Zhang, Sheyu Li
Förderung
- National Science and Technology Major Project
- National Natural Science Foundation of China
- West China Hospital, Sichuan University
Zitieren
APA
An, J., Jia, Q., Huang, Y., Cao, Y., Duan, Y., Zhang, H., & Li, S. (2025). Obesity care in Chinese adults: from evidence to clinical practice. Precision Clinical Medicine, 8(4). https://doi.org/10.1093/pcmedi/pbaf036
Vancouver
An J, Jia Q, Huang Y, Cao Y, Duan Y, Zhang H, et al. Obesity care in Chinese adults: from evidence to clinical practice. Precision Clinical Medicine. 2025;8(4). doi:10.1093/pcmedi/pbaf036
BibTeX
@article{An2025,
author = {An, Jing and Jia, Qingyi and Huang, Yan and Cao, Yuzi and Duan, Yaqian and Zhang, Huijie and Li, Sheyu},
title = {Obesity care in Chinese adults: from evidence to clinical practice},
journal = {Precision Clinical Medicine},
year = {2025},
volume = {8},
number = {4},
doi = {10.1093/pcmedi/pbaf036}
}
EUVIMED